Navigation Links
Mammogram most effective 12 months after radiation treatment
Date:11/25/2008

Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram until 12 months after radiation, despite current American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) guidelines that recommend follow-up mammograms at between six and 12 months after radiation, according to a November 15 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

According to the American Cancer Society, more than 182,000 women will be diagnosed with breast cancer in 2008, and many of these women will choose to undergo a lumpectomy and radiation therapy as their course of treatment, which has been shown to produce similar survival outcomes to a mastectomy. Mammography has been established as a crucial part of post-treatment surveillance for patients undergoing breast-conserving therapy, but the optimal timing of the initial mammogram is not clear.

Researchers at the University of California, Los Angeles, School of Medicine, Department of Radiation Oncology, Department of Pathology, and Department of Radiology and at the University of California, San Diego, School of Medicine sought to determine if the recommended timeframe for a post-treatment mammogram offers any benefit to patients.

The most recent NCCN guidelines proposes a follow-up mammogram six to 12 months after radiation, and according to 2006 guidelines, ASCO recommends a follow-up mammogram one year after the initial mammogram that leads to diagnosis, but no earlier than six months after radiation. Accounting for the time after the initial diagnostic mammogram to have a biopsy, surgery and radiation therapy, following the ASCO guidelines would likely result in mammograms being done six to nine months after the completion of radiation.

The researchers looked at 408 patients who were treated with breast-conserving th
'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Therapeutic Radiology and Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mammograms may detect some cancers that would have otherwise regressed
2. Fear, misconceptions about screenings keep many African-Americans from getting mammograms
3. Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening
4. Mammograms Remain Best Way to Spot Breast Cancer
5. Breast CT Scans Could Be Comfortable Alternative to Mammograms
6. Over-the-counter anesthetic gel puts the squeeze on mammogram pain
7. 6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
8. Mammograms Still a Good Idea for Elderly Women
9. Mammograms benefit women up to the age of 75 and 3-yearly screening intervals are best
10. Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Womens Negative Attitudes Toward Mammograms
11. Hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Negative Pressure Wound Devices Draw FDA Notice, Advice 2UBC researchers find first ever wanderlust gene in tiny bony fish 9474 1Avipaxin Is First Entrant in Medical Arsenal for Neuro Endocrine Immune Connection 28C 29 Product and Testing Protocols 53679 1Avipaxin Is First Entrant in Medical Arsenal for Neuro Endocrine Immune Connection 28C 29 Product and Testing Protocols 53679 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 1Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 3